Biotechnology - Neurological, Research

Filter

Current filters:

NeurologicalResearch

Popular Filters

1 to 25 of 81 results

Merck & Co in new accord with Bionomics for CNS research

Merck & Co in new accord with Bionomics for CNS research

24-06-2014

Australian biotech firm Bionomics has entered into a second exclusive research collaboration and license…

BionomicsBiotechnologyBNC375LicensingMerck & CoNeurologicalResearch

Isis Pharma earns $10 million milestone from Biogen

Isis Pharma earns $10 million milestone from Biogen

17-06-2014

Isis Pharmaceuticals revealed today it has earned a $10 million milestone payment from fellow US biotech…

Biogen IdecBiotechnologyFinancialIsis PharmaceuticalsNeurologicalResearch

KemPharm gets $60 million funding commitment from Deerfield

KemPharm gets $60 million funding commitment from Deerfield

06-06-2014

KemPharm, a clinical-stage US biopharmaceutical company, has entered into a $60 million financing agreement…

BiotechnologyFinancialKemPharmKP201NeurologicalResearch

AFFiRiS reports breakthrough in Alzheimer's disease with AD04

AFFiRiS reports breakthrough in Alzheimer's disease with AD04

05-06-2014

Austrian biotech firm AFFiRiS has released Phase II results with its proprietary AD04 vaccine, saying…

AD04AFFiRiSBiotechnologyGlaxoSmithKlineNeurologicalResearch

Eisai's R&D unit Kan Research Institute starts full-scale operation at new facility

27-05-2014

Japanese drug major Eisai Co says that its R&D subsidiary KAN Research Institute held a dedication ceremony…

BiotechnologyEisaiImmunologicalsJapanKan Research InstituteNeurologicalOncologyResearch

AAN 2014: Biogen Idec releases new trial data for peginterferon in MS

AAN 2014: Biogen Idec releases new trial data for peginterferon in MS

02-05-2014

US biotech firm Biogen Idec has released new two-year data from the Phase III ADVANCE clinical trial…

Biogen IdecBiotechnologyCytokinesHealth Medical PharmaHealth Medical PharmaImmune systemImmunologyNeurologicalpeginterferon beta-1aResearchUSA

AFFiRiS leads consortium for Parkinson’s vaccine funded by EU

AFFiRiS leads consortium for Parkinson’s vaccine funded by EU

29-04-2014

An international consortium of top European research teams has received significant European Union funding…

Achim SchneebergerAFFiRiSAustriaBiologyBiotechnologyEuropeExperts and basic scientistMedical University of Innsbruck's DepartmentMedicineNeurologicalResearchVaccines

Biogen Idec 1st-qtr 2014 revenue leaps 51%, driven by Tecfidera and MS franchise

23-04-2014

US biotech firm Biogen Idec first-quarter 2014 results today, including revenue of $2.1 billion, a 51%…

Biogen IdecBiotechnologyFinancialNeurologicalResearchTecfidera

Alkermes leaps on positive Ph III results for aripiprazole lauroxil for schizophrenia

Alkermes leaps on positive Ph III results for aripiprazole lauroxil for schizophrenia

09-04-2014

US biotech firm Alkermes saw its shares spike on Tuesday, after it announced positive top-line results…

AbilifyAlkermesaripiprazole lauroxilBiotechnologyLundbeckNeurologicalOtsukaRegulationResearch

Convergence Pharma and Evotec collaborate on chronic pain drugs

Convergence Pharma and Evotec collaborate on chronic pain drugs

31-03-2014

Independent UK biotech firm Convergence Pharmaceuticals has entered into a research alliance with Germany’s…

BiotechnologyConvergence PharmaceuticalsEvotecNeurologicalResearch

Xenon and Genentech establish new pain discovery collaboration

26-03-2014

Privately-held US biotech firm Xenon Pharmaceuticals has established a new collaboration with Swiss drug…

BiotechnologyGenentechLicensingNeurologicalResearchRocheXenon Pharmaceuticals

Eisai and Biogen Idec collaborate on Alzheimer’s disease treatments

Eisai and Biogen Idec collaborate on Alzheimer’s disease treatments

05-03-2014

US biotech firm Biogen Idec and Japanese drugmaker Eisai have entered into a collaboration to develop…

BAN2401BIIB037Biogen IdecBiotechnologyE2609EisaiLicensingNeurologicalResearch

Vitae Pharma earns $14 million milestone from Boehringer Ingelheim in Alzheimer's collaboration

Vitae Pharma earns $14 million milestone from Boehringer Ingelheim in Alzheimer's collaboration

20-02-2014

US clinical-stage biotech firm Vitae Pharmaceuticals says it has earned a $14 million milestone payment…

BiotechnologyBoehringer IngelheimFinancialNeurologicalResearchVitae Pharmaceuticals

Prana reports successful Phase II results in Huntington disease trial

18-02-2014

Australia-based Prana Biotechnology has announced positive results of its Reach2HD Phase II clinical…

AustraliaBiotechnologyCNS DiseasesNeurologicalPrana BiotechnologyResearch

Amarantus’ eltoprazine positive in mid-stage adult ADHD study

Amarantus’ eltoprazine positive in mid-stage adult ADHD study

04-02-2014

US biotech firm Amarantus Bioscience has released positive clinical data for eltoprazine in a Phase IIa…

Amarantus BioscienceBiotechnologyeltoprazineNeurologicalResearch

Neurocrine rockets on positive Phase II data for tardive dyskinesia treatment

08-01-2014

Shares of Neurocrine Biosciences were up almost 80% yesterday after it announced that NBI-98854, a small…

BiotechnologyNeurocrine BiosciencesNeurologicalResearchUSA

Prothena inks deal with Roche, worth a potential $600 million

Prothena inks deal with Roche, worth a potential $600 million

12-12-2013

Biotech firm Prothena has entered into a worldwide collaboration with Swiss drug major Roche to develop…

BiotechnologyGlobalLicensingNeurologicalProthenaPRX002ResearchRoche

Proteostasis Therapeutics in neurodegenerative disease deal with Biogen Idec

Proteostasis Therapeutics in neurodegenerative disease deal with Biogen Idec

10-12-2013

US drug developer Proteostasis Therapeutics has entered into a worldwide collaboration with biotech major…

Biogen IdecBiotechnologyLicensingNeurologicalProteostasis TherapeuticsResearch

Germany’s Merck invests in further research partnerships in Israel

Germany’s Merck invests in further research partnerships in Israel

26-11-2013

German pharma and chemicals firm Merck KGaA says it is increasingly counting on partnerships with Israeli…

BiotechnologyChanBioFinancialMerck KGaAMetabomedNeurologicalOncologyResearchRest of the World

Aphios spins off Amylon to develop novel Alzheimer’s disease drug

21-11-2013

US clinical-stage biotech firm Aphios says it has spun-off a subsidiary, Amylon, to finance, develop…

AmylonAPH-1104AphiosBiotechnologyFinancialMergers & AcquisitionsNeurologicalResearch

Zalicus slumps as pain drug Z160 fails in Ph II

11-11-2013

US biotech firm Zalicus saw its shares plunge 71.5% in early trading, after the company revealed announced…

BiotechnologyNeurologicalResearchZ944Zalicus

Positive new Ph III data for ACADIA Pharma’s pimavanserin in Parkinson’s

01-11-2013

US biotech firm ACADIA Pharmaceuticalssays that new date published in the on-line edition of The Lancet…

ACADIA PharmaceuticalsBiotechnologyBiovailNeurologicalpimavanserinResearch

Biogen Idec presents new Tecfidera data in MS at ECTRIMS

04-10-2013

Biogen Idec presented data showing that Tecfidera continues to offer consistent and strong efficacy combined…

Biogen IdecBiotechnologyNeurologicalResearchTecfidera

1 to 25 of 81 results

Back to top